kw.\*:("Oral glucose-lowering agents Type 2 diabetes")
Results 1 to 1 of 1
Selection :
A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetesROSENSTOCK, J; DAVIES, M; HOME, P. D et al.Diabetologia (Berlin). 2008, Vol 51, Num 3, pp 408-416, issn 0012-186X, 9 p.Article
